Hillhouse Capital Management - Q4 2018 holdings

$1.34 Billion is the total value of Hillhouse Capital Management's 24 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 60.0% .

 Value Shares↓ Weighting
IQ BuyIQIYI INCsponsored ads$510,235,000
+852.4%
34,313,024
+1633.8%
38.21%
+2568.4%
ESGR  ENSTAR GROUP LIMITED$292,886,000
-19.6%
1,747,8400.0%21.93%
+125.2%
BGNE SellBEIGENE LTDsponsored adr$145,072,000
-84.6%
1,034,306
-81.1%
10.86%
-56.9%
UXIN BuyUXIN LTDads$108,136,000
+684.0%
22,250,160
+995.3%
8.10%
+2094.6%
BABA SellALIBABA GROUP HLDG LTDsponsored ads$54,189,000
-21.9%
395,340
-6.1%
4.06%
+118.9%
PDD SellPINDUODUO INCsponsored ads$32,327,000
-42.1%
1,440,605
-32.1%
2.42%
+62.4%
FB BuyFACEBOOK INCcl a$30,855,000
+204.2%
235,374
+281.7%
2.31%
+752.8%
APLS SellAPELLIS PHARMACEUTICALS INC$27,680,000
-64.0%
2,098,581
-51.5%
2.07%
+0.8%
MSCI BuyMSCI INC$17,205,000
+34.0%
116,701
+61.2%
1.29%
+275.5%
AAPL BuyAPPLE INC$17,182,000
+18.4%
108,923
+69.4%
1.29%
+231.7%
MRNA NewMODERNA INC$14,941,000978,434
+100.0%
1.12%
AMZN BuyAMAZON COM INC$11,920,000
+69.5%
7,936
+126.1%
0.89%
+375.0%
JD SellJD COM INCspon adr cl a$11,687,000
-97.9%
558,400
-97.4%
0.88%
-94.1%
GSAHU  GS ACQUISITION HLDGS CORPunit 06/12/2023$10,250,000
-0.5%
1,000,0000.0%0.77%
+179.3%
CJJD  CHINA JO-JO DRUGSTORES INC$9,680,000
+24.2%
4,840,0000.0%0.72%
+248.6%
BILI BuyBILIBILI INCspons ads rep z$9,111,000
+4695.3%
624,500
+4341.4%
0.68%
+13540.0%
BRKA SellBERKSHIRE HATHAWAY INC DELcl a$7,650,000
-53.1%
25
-51.0%
0.57%
+31.4%
GOOG BuyALPHABET INCcap stk cl c$6,917,000
+8.2%
6,679
+24.7%
0.52%
+202.9%
NFLX SellNETFLIX INC$6,502,000
-46.3%
24,292
-25.0%
0.49%
+50.3%
RCUS SellARCUS BIOSCIENCES INC$3,685,000
-65.5%
342,128
-55.4%
0.28%
-3.5%
ARVN SellARVINAS INC$2,959,000
-79.5%
230,308
-73.1%
0.22%
-42.5%
NTGN SellNEON THERAPEUTICS INC$2,009,000
-67.0%
399,308
-43.9%
0.15%
-7.4%
CNST  CONSTELLATION PHARMCETICLS I$1,275,000
-40.4%
317,9210.0%0.10%
+66.7%
APO NewAPOLLO GLOBAL MGMT LLC$925,00037,678
+100.0%
0.07%
PTI ExitPROTEOSTASIS THERAPEUTICS IN$0-865,923
-100.0%
-0.06%
EIDX ExitEIDOS THERAPEUTICS INC$0-225,000
-100.0%
-0.06%
SFUN ExitFANG HLDGS LTDadr$0-1,500,000
-100.0%
-0.10%
SPGI ExitS&P GLOBAL INC$0-24,387
-100.0%
-0.13%
NEW ExitPUXIN LTDads$0-903,494
-100.0%
-0.21%
IDXX ExitIDEXX LABS INC$0-33,380
-100.0%
-0.22%
VRSN ExitVERISIGN INC$0-75,711
-100.0%
-0.32%
NKE ExitNIKE INCcl b$0-143,741
-100.0%
-0.32%
FTCH ExitFARFETCH LTDord sh cl a$0-500,000
-100.0%
-0.36%
YY ExitYY INC$0-193,490
-100.0%
-0.39%
MCO ExitMOODYS CORP$0-89,949
-100.0%
-0.40%
SOHU ExitSOHU COM LTDsponsored ads$0-802,034
-100.0%
-0.43%
MLCO ExitMELCO RESORT ENTERTAINMENT Ladr$0-913,329
-100.0%
-0.52%
LOXO ExitLOXO ONCOLOGY INC$0-131,300
-100.0%
-0.60%
KNSA ExitKINIKSA PHARMACEUTICALS LTD$0-1,388,888
-100.0%
-0.95%
XLRN ExitACCELERON PHARMA INC$0-813,600
-100.0%
-1.24%
BEDU ExitBRIGHT SCHOLAR ED HLDGS LTDsponsored ads$0-3,985,797
-100.0%
-1.32%
GTHX ExitG1 THERAPEUTICS INC$0-949,431
-100.0%
-1.33%
LN ExitLINE CORPsponsored adr$0-1,207,763
-100.0%
-1.36%
TAL ExitTAL ED GROUPsponsored ads$0-2,024,450
-100.0%
-1.39%
KANG ExitIKANG HEALTHCARE GROUP INCsponsored adr$0-2,922,834
-100.0%
-1.41%
MYOK ExitMYOKARDIA INC$0-858,340
-100.0%
-1.50%
SNAP ExitSNAP INCcl a$0-10,989,529
-100.0%
-2.49%
BPMC ExitBLUEPRINT MEDICINES CORP$0-1,430,949
-100.0%
-2.98%
MDLZ ExitMONDELEZ INTL INCcl a$0-3,529,264
-100.0%
-4.05%
FGEN ExitFIBROGEN INC$0-2,686,196
-100.0%
-4.36%
WUBA Exit58 COM INCspon adr rep a$0-2,638,675
-100.0%
-5.19%
CBPO ExitCHINA BIOLOGIC PRODS HLDGS I$0-2,751,200
-100.0%
-5.88%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2019-02-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MONDELEZ INTL INC22Q3 201844.4%
JD COM INC19Q2 201980.2%
SOHU COM INC19Q1 201813.4%
58 COM INC18Q3 20187.8%
TAL EDUCATION GROUP18Q2 20194.4%
CTRIP COM INTL LTD17Q2 201728.4%
BEIGENE LTD14Q2 201925.2%
MELCO RESORT ENTERTAINMENT L14Q3 20186.4%
CAMECO CORP14Q4 20172.2%
ENSTAR GROUP LIMITED12Q2 201921.9%

View Hillhouse Capital Management's complete holdings history.

Latest significant ownerships (13-D/G)
Hillhouse Capital Management Q4 2018 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
China Jo-Jo Drugstores Holdings, Inc.February 14, 2023403,3344.7%
TScan Therapeutics, Inc.February 14, 2023? ?
Enfusion, Inc.February 14, 20224,975,1837.6%
Enstar Group LTDJuly 19, 2021? ?
Zoom Video Communications, Inc.February 16, 20212,981,2651.5%
NIO Inc.February 14, 2020? ?
Sea LtdFebruary 14, 20204,300,0002.3%
Uxin LtdFebruary 14, 202021,733,0232.6%
Apellis Pharmaceuticals, Inc.February 14, 20192,098,5813.7%
iQIYI, Inc.February 14, 2019240,191,17411.0%

View Hillhouse Capital Management's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G/A2024-03-05
13F-NT2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G2024-02-14
SC 13G2024-02-14
42024-02-01
32024-01-25
13F-NT2023-11-14
13F-NT2023-08-14

View Hillhouse Capital Management's complete filings history.

Compare quarters

Export Hillhouse Capital Management's holdings